Osteogenesis Imperfecta

Current Clinical Trial

Name:

Osteogenesis Imperfecta

Description:

Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid (TOPaZ)

Stage:

Ongoing, closed to recruitment

Principal Investigator:

Prof Rachel Crowley

Sponsor:

University of Edinburgh

Network Partners